This training program will provide practical pointers on documenting the recall decision. Recall can be a very costly process for a manufacturer. It is really important from a regulatory perspective to properly document the decision process whether a recall is necessary or not. The new guidance can help provide some direction in making the decision. Though guidance documents are not binding, they do tend to reflect the current thinking of the FDA. Beyond the guidance, the webinar will also illustrate best practices for documenting the recall process in the event that you determine a recall is warranted.
Why Should You Attend:
In October 2014, FDA published a new guidance entitled 'Distinguishing Medical Device Recalls from Medical Device Enhancements'. This guidance is intended to:- Clarify when a change to a device constitutes a medical device recall
- Distinguish those instances from device enhancements that do not meet the definition of a medical device recall
- Clarify reporting requirements under 21 CFR §806
- The guidance should not be used alone but instead should be applied in conjunction with 21 CFR §806 and if applicable, 21 CFR §7, subpart c. This webinar will discuss the primary points of the new guidance, review 21 CFR §806 and i21 CFR §7, subpart c, as well as how to document your recall decision and what is needed if a recall is warranted.
Areas Covered in the Webinar:
- Background of the new guidance
- 21 CFR §806
- 21 CFR §7, subpart c
- When is a change a recall?
- When is a change not a recall?
- Examples
- Documenting the decision
- Documenting the recall process
- Q&A
Who Will Benefit:
This webinar will provide valuable assistance to all personnel in:- Regulatory roles
- Quality assurance management
- Manufacturing management responsible for executing recall activities
- Project managers and staff involved with recalls
Course Provider
Cheryl Wagoner,
